期刊文献+

Therapeutic potential of antibodies against interleukin 5 in asthma 被引量:1

Therapeutic potential of antibodies against interleukin 5 in asthma
原文传递
导出
摘要 Bronchial asthma is characterized by chronic recruitment of eosinophils in the airways. It has been reported that bronchial eosinophil recruitment and activation may even occur in mild-moderate stable asthma and that bronchial epithelium damage and airway responsiveness may be partially associated with the eosinophilic inflammatory reaction.1 There is increasing evidence that the eosinophil-rich bronchial inflammation characteristic of asthma is orchestrated, at least partly, Bronchial asthma is characterized by chronic recruitment of eosinophils in the airways. It has been reported that bronchial eosinophil recruitment and activation may even occur in mild-moderate stable asthma and that bronchial epithelium damage and airway responsiveness may be partially associated with the eosinophilic inflammatory reaction.1 There is increasing evidence that the eosinophil-rich bronchial inflammation characteristic of asthma is orchestrated, at least partly,
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第12期1363-1364,共2页 中华医学杂志(英文版)
  • 相关文献

参考文献15

  • 1Oddera S, Silvestri Balbo MA, Jovovich BO, Penna R, Crimi E, Rossi GA. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy 1996; 51: 100-107.
  • 2Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79: 3101-3109.
  • 3Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990; 144: 642-646.
  • 4Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson C J, Kay AB. IL-5 enhances the in vivo adhesion of human eosinophils, but not neutrophils, in a leukocytes integrin (CD11/18)-dependent manner. Immunology 1990; 71: 258-265.
  • 5Van Oosterhout AJ, Ladenius AR, Savelkoul HE Van Ark I, Delsman KC, Nijkamp FP. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993; 147: 548-552.
  • 6Foster PS, Hogan SP, Ramsay A J, Matthaei KI, Young IG .Intedeukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195-201.
  • 7Shi HZ, Qin SM, Huang GW, Chen YQ, Xiao CQ, Liang GR, et al. Infiltration of eosinophils into the asthmatic airways caused by interleukin-5. Am J Respir Cell Mol Biol 1997; 16: 220-224.
  • 8Shi HZ, Xiao CQ, Zhong D, Qin SM, Liu Y, Liang GR, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Clin Exp Allergy 2007; 37: 1023-1032.
  • 9Gnanakumaran G, Babu KS. Technology evaluation: mepolizumab, GlaxoSmithKline. Curr Opin Mol Ther 2003; 5: 321-325.
  • 10Leckie M J, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-2148.

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部